We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Recalls, Investigation Result In KV Investors' Suit

Law360 (December 3, 2008, 12:00 AM EST) -- Investors in KV Pharmaceutical Co. have alleged that the company knowingly made materially false statements about its earnings and product lines throughout 2008, and that they suffered severe economic damage as a result.

In a complaint filed Tuesday in the U.S. District Court for the Eastern District of Missouri, the potential investor class claims that a torrent of information, including drug recalls, an internal ethics investigation, the delay of regulatory filings and the subsequent withdrawal of rosy 2009 revenue forecasts, caused KV stock to lose more...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.